Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Elena García-Martínez"'
Autor:
Esmeralda García-Torralba, Esther Navarro Manzano, Gines Luengo-Gil, Pilar De la Morena Barrio, Asunción Chaves Benito, Miguel Pérez-Ramos, Beatriz Álvarez-Abril, Alejandra Ivars Rubio, Elisa García-Garre, Francisco Ayala de la Peña, Elena García-Martínez
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundUp to 30% of breast cancer (BC) patients treated with neoadjuvant chemotherapy (NCT) will relapse. Our objective was to analyze the predictive capacity of several markers associated with immune response and cell proliferation combined with
Externí odkaz:
https://doaj.org/article/45fb4d2560e8406c9b0a23f5e2b11e43
Autor:
Esmeralda García-Torralba, Miguel Pérez Ramos, Alejandra Ivars Rubio, Esther Navarro-Manzano, Noel Blaya Boluda, Pilar de la Morena Barrio, Elisa García-Garre, Francisco Martínez Díaz, Asunción Chaves-Benito, Elena García-Martínez, Francisco Ayala de la Peña
Publikováno v:
Cancers, Vol 15, Iss 10, p 2846 (2023)
Luminal breast cancer (BC) is associated with less immune activation, and the significance of stromal lymphocytic infiltration (sTIL) is more uncertain than in other BC subtypes. The aim of this study was to investigate the predictive and prognostic
Externí odkaz:
https://doaj.org/article/27dfeb1b4c474624ba02472b3566ba6c
Publikováno v:
EJC Supplements, Vol 15, Iss , Pp 87-95 (2020)
Ovarian cancer is the leading cause of death for gynaecological cancer, and new therapies are urgently awaited. Although the presence of tumour-infiltrating lymphocytes has been confirmed to be associated to a better prognosis, immunotherapy is not y
Externí odkaz:
https://doaj.org/article/3d0201401d5d49ad8cb51be58274c19c
Autor:
Esther Navarro-Manzano, Ginés Luengo-Gil, Rocío González-Conejero, Elisa García-Garre, Elena García-Martínez, Esmeralda García-Torralba, Asunción Chaves-Benito, Vicente Vicente, Francisco Ayala de la Peña
Publikováno v:
Cancers, Vol 14, Iss 10, p 2390 (2022)
While the role of miR-200c in cancer progression has been established, its expression and prognostic role in breast cancer is not completely understood. The predictive role of miR-200c in response to chemotherapy has also been suggested by some studi
Externí odkaz:
https://doaj.org/article/04e787deaed74c8bb11c51b476395820
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/75602d9369494f7e9309d93769272da2
Autor:
Alba Gutiérrez-Seijo, Elena García-Martínez, Celia Barrio-Alonso, Miriam Pareja-Malagón, Alejandra Acosta-Ocampo, María Eugenia Fernández-Santos, Amaya Puig-Kröger, Verónica Parra-Blanco, Enrique Mercader, Iván Márquez-Rodas, José Antonio Avilés-Izquierdo, Rafael Samaniego, Paloma Sánchez-Mateos
Publikováno v:
Cancers, Vol 13, Iss 16, p 3943 (2021)
TAMs constitute a large fraction of infiltrating immune cells in melanoma tissues, but their significance for clinical outcomes remains unclear. We explored diverse TAM parameters in clinically relevant primary cutaneous melanoma samples, including d
Externí odkaz:
https://doaj.org/article/6d65ff43b1f543518e79a4ce3637c8fc
Autor:
Teresa López-Viñau, Germán Peñalva, Lucrecia García-Martínez, Juan José Castón, Montserrat Muñoz-Rosa, Ángela Cano, Manuel Recio, José Miguel Cisneros, Elena Pérez-Nadales, José Rumbao Aguirre, Elena García-Martínez, Inmaculada Salcedo, José Ramón del Prado, Carmen de la Fuente, Luis Martínez-Martínez, Irene Gracia-Ahufinger, Julián Torre-Cisneros
Publikováno v:
Antibiotics, Vol 10, Iss 5, p 586 (2021)
Carbapenem-resistant Gram-negative bacilli (CR-GNB) are a critical public health threat, and carbapenem use contributes to their spread. Antimicrobial stewardship programs (ASPs) have proven successful in reducing antimicrobial use. However, evidence
Externí odkaz:
https://doaj.org/article/565a9b8e26154acea297fd1240f33c67
Autor:
Melody Smith, Elena García-Martínez, Michael R. Pitter, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi
Publikováno v:
OncoImmunology, Vol 7, Iss 12 (2018)
Toll-like receptor (TLR) agonists demonstrate therapeutic promise as immunological adjuvants for anticancer immunotherapy. To date, three TLR agonists have been approved by US regulatory agencies for use in cancer patients. Additionally, the potentia
Externí odkaz:
https://doaj.org/article/07912379e76c40a9919d49990f8f46dc
Autor:
Elena García-Martínez, Melody Smith, Aitziber Buqué, Fernando Aranda, Francisco Ayala de la Peña, Alejandra Ivars, Manuel Sanchez Cánovas, Ma Angeles Vicente Conesa, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi
Publikováno v:
OncoImmunology, Vol 7, Iss 6 (2018)
Cytokines regulate virtually aspects of innate and adaptive immunity, including the initiation, execution and extinction of tumor-targeting immune responses. Over the past three decades, the possibility of using recombinant cytokines as a means to el
Externí odkaz:
https://doaj.org/article/6731cb15153b4509a97d8f6329ec4567
Publikováno v:
Ge-conservacion. 23:17-26
Las diferentes leyes autonómicas de patrimonio cultural y el borrador de la reforma de la Ley del Patrimonio Histórico Español (Ministerio de Cultura y Deporte 2021) reflejan la evolución de los conceptos patrimoniales, ampliando las categorías